Your session is about to expire
← Back to Search
tDCS for ADHD
Study Summary
This trial is testing whether a home-based tDCS device can help improve symptoms of ADHD and cognitive control over a four week period. They are also testing whether there is a dose-dependent response to tDCS.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old.You cannot participate if you have a history of epilepsy, have metal implants in your head or neck, have brain or vagus nerve stimulators, have a VP shunt, have a pacemaker, or are pregnant.I have a history of serious brain conditions or severe mental health issues.I have been diagnosed with ADD/ADHD.You are currently dependent on drugs or alcohol, except for tobacco.I cannot take part in the required testing for the study.
- Group 1: 2mA transcranial direct current stimulation
- Group 2: 1mA transcranial direct current stimulation
- Group 3: Sham transcranial direct current stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research include geriatric participants?
"This research project is seeking participants aged 18 to 65."
Are there any available slots for participants in this research trial?
"Affirmative. The details found on clinicaltrials.gov suggest that this research project is presently recruiting individuals for the trial, which was first made public on July 1st 2022 and has been refreshed as recently as July 21st 2022. Sixty people are required to be enrolled at one medical site."
Could I potentially join this clinical trial?
"This clinical trial is seeking 60 male and female outpatients between the ages of 18-65 to participate. All potential enrollees must have been diagnosed with Attention Deficit Hyperactivity Disorder - Inattentive Type, or meet the criteria outlined in DSM-5 for such a diagnosis."
How many participants are accepted in this clinical trial?
"Affirmative, clinicaltrials.gov reports that this examination is currently enrolling participants. The trial was first advertised on July 1st 2022 and has since had its details amended. 60 volunteers are required from a single medical facility."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger